Perioperative cardiovascular outcome in patients with coronary artery disease undergoing major vascular surgery: A

Diana Thomas1, S Sharmila1, M S Saravana Babu1

  • 1Division of Cardiothoracic and Vascular Anesthesia, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Trivandrum, Kerala, India.

Insights

Major adverse cardiac events (MACE) in patients with coronary artery disease (CAD) undergoing aortic surgery are frequent and deadly. Preoperative optimization is key to reducing MACE risk.

Area of Science:

  • Cardiology
  • Vascular Surgery
  • Anesthesiology

Background:

  • Major adverse cardiac events (MACE) significantly contribute to morbidity and mortality in patients undergoing major vascular surgeries.
  • Coronary artery disease (CAD) is a critical comorbidity in patients undergoing aortic surgeries.
  • Assessing MACE incidence, risk factors, and outcomes in CAD patients undergoing aortic surgery is crucial.

Purpose of the Study:

  • To evaluate the incidence of MACE in patients with CAD undergoing aortic surgeries.
  • To identify risk factors associated with MACE in this patient population.
  • To determine the outcomes of MACE in patients undergoing aortic surgery.

Main Methods:

  • Retrospective observational study of 141 patients with CAD undergoing elective major vascular aortic surgeries from 2010-2019.
  • Analysis of preoperative risk factors including revised cardiac risk index, functional status, CAD severity, and treatment.
  • Evaluation of anesthesia techniques, including general anesthesia with or without epidural analgesia.

Main Results:

  • Perioperative MACE incidence was 11.3% (16/141), with an overall in-hospital mortality of 6.4% (9/141), all MACE-related.
  • Patients who underwent preoperative coronary revascularization had a higher odds of MACE (OR: 3.9; 95% CI, 1.34-11.34).
  • Epidural analgesia added to general anesthesia did not reduce perioperative MACE.

Conclusions:

  • Major vascular surgeries in CAD patients are high-risk procedures with significant mortality associated with perioperative MACE.
  • Early detection and medical optimization of CAD are vital for mitigating MACE risk.
  • Risk stratification and tailored preoperative management are essential for improving outcomes.
Abstract

Related Concept Videos

Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
27
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
22
Aneurysm IV: Nursing Management01:22

Aneurysm IV: Nursing Management

Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...
18
Cardiac Catheterization IV: Nursing Management01:26

Cardiac Catheterization IV: Nursing Management

Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
182
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
27
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
146